Arovella Therapeutics (ARVEF) Q1 2025 Earnings

Feb 27Confirmed
Q3 2024
Q1 2025
-0
-0
-0
-0

Details

Expected EPS
-0.00123734
Actual EPS
-0.000866138
Surprise EPS
0
Surprise Percent
+30%

Description

⁨Arovella Therapeutics⁩ (⁦ARVEF⁩) has reported earnings of ⁦-0.000866138⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts